Cargando…
CRISPR/Cas9 Editing for Gaucher Disease Modelling
Gaucher disease (GD) is an autosomal recessive lysosomal storage disorder caused by mutations in the acid β-glucosidase gene (GBA1). Besides causing GD, GBA1 mutations constitute the main genetic risk factor for developing Parkinson’s disease. The molecular basis of neurological manifestations in GD...
Autores principales: | Pavan, Eleonora, Ormazabal, Maximiliano, Peruzzo, Paolo, Vaena, Emilio, Rozenfeld, Paula, Dardis, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246564/ https://www.ncbi.nlm.nih.gov/pubmed/32380730 http://dx.doi.org/10.3390/ijms21093268 |
Ejemplares similares
-
Exploring the Pathophysiologic Cascade Leading to Osteoclastogenic Activation in Gaucher Disease Monocytes Generated via CRISPR/Cas9 Technology
por: Ormazabal, Maximiliano Emanuel, et al.
Publicado: (2023) -
Bone marrow adipocytes alteration in an in vitro model of Gaucher Disease
por: Crivaro, A., et al.
Publicado: (2023) -
Osteocyte Alterations Induce Osteoclastogenesis in an In Vitro Model of Gaucher Disease
por: Bondar, Constanza, et al.
Publicado: (2017) -
Efficacy of pentosan polysulfate in in vitro models of lysosomal storage disorders: Fabry and Gaucher Disease
por: Crivaro, Andrea N., et al.
Publicado: (2019) -
Accurate Molecular Diagnosis of Gaucher Disease Using Clinical Exome Sequencing as a First-Tier Test
por: Zampieri, Stefania, et al.
Publicado: (2021)